
The CEOs of Pfizer Inc (NYSE:PFE), BioNTech SE (NASDAQ:BNTX), and Moderna Inc (NASDAQ:MRNA) have shared more than $100 million in pay during the pandemic reflecting the success of the mRNA-based COVID-19 vaccines developed by their companies.
Pfizers' Albert Bourla, Ugur Sahin of BioNTech, and Stéphane Bancel of Moderna have also seen an increase in their paper wealth thanks to the rise in share price driven by investor enthusiasm.